文献速递甲状腺疾病

消除分化型甲状腺癌分期中的年龄截断值:最安全的路径?

Eliminating the Age Cutoff in Staging of Differentiated Thyroid Cancer: The Safest Road?
PubMed 文献 · J Clin Endocrinol Metab · 2018-01-01

该观点文章回顾了甲状腺癌分期中年龄截断值(45岁,2018年第八版AJCC改为55岁)的依据,指出多数研究仅报告年龄与生存的关联,不支持特定截断值,而提示年龄作为连续变量影响结局,建议寻找年龄相关预后变量以完善分期系统。

要点

  • 甲状腺癌是唯一将年龄作为分期关键组分的癌症。
  • 多数研究显示年龄与生存相关,但不支持特定年龄截断值。
  • 年龄可能作为连续变量影响预后,需寻找年龄相关预后变量。

核心结论

  • 年龄仅在甲状腺癌分期中具有重要作用,考虑年龄为连续变量并寻找年龄相关预后变量可能阐明更准确的分期系统。

研究设计与样本

  • 观点文章,回顾了关于甲状腺癌分期的临床与基础研究、综述及既往共识声明。

主要发现

  • 多数研究报道年龄与甲状腺癌生存相关,但不支持特定年龄截断值。
  • 研究提示结局受年龄作为连续变量的影响。
  • 其他因素可能随时间与年龄持续交互影响预后。

关键数值与推荐

  • 全球病理学家和临床医生曾接受45岁作为分期年龄截断值。
  • 2018年第八版美国癌症联合委员会分期系统将年龄截断值推进至55岁。

临床怎么用

  • 原文未涉及临床实践建议。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Unlike virtually all other cancer types, thyroid cancer is unique in that patient age is a key component in its staging. Pathologists and clinicians worldwide have accepted an age cutoff of 45 years for staging; in 2018, this advances to age 55 years in the eighth edition of the American Joint Commission on Cancer staging system. EVIDENCE ACQUISITION: Clinical and basic research studies, reviews, and previous editions of consensus statements regarding thyroid cancer staging were reviewed, with particular focus on the influence of age in thyroid cancer prognosis. PURPOSE: This perspective briefly reviews the basis for this practice and challenges it as no more appropriate than for other malignancies. EVIDENCE SYNTHESIS: The majority of findings report an association of age with thyroid cancer survival but do not support a specific age cutoff; rather, they suggest that outcome is affected by age as a continuous variable. Conceivably, other factors interact with age on a continuous basis over time, affecting prognosis. When identified, these factors could alter our current concept of the importance of an age cutoff in staging. CONCLUSIONS: Among all cancers, age has an important role in only thyroid cancer staging. The consideration of age as a continuous variable and the search for age-associated prognostic variables could elucidate a more accurate staging system.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Ylli D, Burman KD, Van Nostrand D, et al. Eliminating the Age Cutoff in Staging of Differentiated Thyroid Cancer: The Safest Road? J Clin Endocrinol Metab. 2018. PMID: 29741712. doi:10.1210/jc.2017-02725

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。